
A strong positive correlation between cell free-DNA levels and COVID-19 severity exists among kidney transplant patients, according to data published in Transplant Proceedings.
Further, researchers found cell free-DNA (cfDNA) levels are elevated at time of the infection and lower once the infection fades.
“Kidney transplant recipients are at high risk for developing severe COVID-19. Lowering immunosuppression levels in kidney transplant recipients with COVID-19 encourages native immune responses but can raise the risk of rejection. Donor-derived cell-free DNA (dd-cfDNA), reported as a